Cambridge Investment Research Advisors
TMDX icon

Cambridge Investment Research Advisors’s Transmedics TMDX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
16,456
-989
-6% -$83.7K ﹤0.01% 2068
2026
Q1 		$1.73M Sell
17,445
-224
-1% -$29.2K ﹤0.01% 1705
2025
Q4 		$2.15M Buy
17,669
+1,064
+6% +$134K 0.01% 1463
2025
Q3 		$1.86M Buy
16,605
+1,477
+10% +$173K 0.01% 1558
2025
Q2 		$2.03M Buy
15,128
+3,436
+29% +$377K 0.01% 1429
2025
Q1 		$787K Buy
11,692
+4,643
+66% +$319K ﹤0.01% 2053
2024
Q4 		$440K Buy
7,049
+4,445
+171% +$414K ﹤0.01% 2534
2024
Q3 		$409K Hold
2,604
– – ﹤0.01% 2573
2024
Q2 		$392K Sell
2,604
-581
-18% -$69.7K ﹤0.01% 2487
2024
Q1 		$235K Buy
+3,185
New +$263K ﹤0.01% 2887

Other funds holding TMDX

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Cambridge Investment Research Advisors's TMDX Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Transmedics (TMDX) stake by 5.7% in Q2 2026, selling an estimated $83.7K and leaving 16,456 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Cambridge Investment Research Advisors first reported a position in TMDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.15M in Q4 2025. 89 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Cambridge Investment Research Advisors held 16,456 shares of Transmedics worth $1.09M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 989 Transmedics shares in Q2 2026, an estimated $83.7K.
  • Transmedics made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2068 holding.
  • Cambridge Investment Research Advisors first reported a position in Transmedics in Q1 2024 and has held it in 10 quarters since.
  • Cambridge Investment Research Advisors's Transmedics position peaked at $2.15M in Q4 2025.
  • 89 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.